Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

I’ve been involved with the Rebelle Rally since its inception in 2016, either as a competitor or live show host, and over the ...

One year after the launch of the Runaki Project - meaning “light” in Kurdish - an ambitious initiative designed to provide 24 ...

The Confederated Tribes of the Colville Reservation in northern Washington state and OATI will install four solar and energy ...